CSPI Newsroom
Return to the Center for Science in the Public Interest
For Immediate
Release:
August 1, 2003

Related Links:
Olestra Linked to Gastrointestinal Disease

More on Olestra


Keep Updated:
Email updates
RSS syndication xml icon


Print Version

For more information, contact: phone 202.332.9110 fax 202.265.4954 Center for Science in the Public Interest, 1875 Connecticut Avenue, NW Washington, DC 20009

FDA Caves in on Olestra

Statement of CSPI Executive Director Michael F. Jacobson

Today's FDA action on olestra is a mistake that will inflict needless misery, inconvenience, and embarrassment for countless Americans. Procter & Gamble's own studies prove olestra causes diarrhea, cramps, and other symptoms. If that weren't enough, the FDA has more than 20,000 complaints about olestra in its files--more than it has for all other food additives in history combined.

Fortunately, since consumers don't seem to like the taste, texture, or side-effects of olestra, the marketshare for olestra-containing chips has diminished. But without an adequate warning label, olestra-containing chips may inadvertently find their way into shopping carts and lunchboxes of even those consumers who are trying to avoid olestra.

This is just another in a string of setbacks for the public's health, engineered by an FDA that seems all too eager to do the bidding of big food companies.